The unbalance between RANKL and OPG contributes to NSCLC development in vivo6; in xenograft mice model has been demonstrated that RANKL overexpression promoted bone destruction and tumor growth of NSCLC cells18. This evidence concerns the gene TNFRSF11B and neoplasm.